close 74% de inversores minoristas pierde dinero cuando opera con CFDs en este proveedor. Las inversiones conllevan riesgos y no son adecuadas para todos los inversores. Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento. 74% de inversores minoristas pierde dinero cuando opera con CFDs en este proveedor. Debes considerar si comprendes cómo funcionan los CFDs y si puedes permitirte asumir el alto riesgo de perder tu dinero.
BuscarBuscar
Dashboard

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

Inicio・Lista de Acciones・Nektar Therapeutics
Search

Nektar Therapeutics

Cerrado

68.46 -3.4

Compra Fuerte

Precios actualizados 27 mar 2026, 19:59 UTC

ComprarVender

Resumen

Variación precio

24h

Actual

Mínimo

67.46

Máximo

70.3

Métricas clave

By Trading Economics

Ingresos

-557K

-36M

Ventas

10M

22M

BPA

-1.29

Margen de beneficios

-165.447

Empleados

63

EBITDA

10M

-19M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+79.41% upside

Dividendos

By Dow Jones

Próximas Ganancias

7 may 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

198M

2.1B

Apertura anterior

71.86

Cierre anterior

68.46

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

0.5949 / 0.7406 Soporte y Resistencia

Nektar Therapeutics Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

27 mar 2026, 17:33 UTC

Noticias de Eventos Importantes

ECB Should Not Rush Its Response to Iran Conflict, Says Schnabel -- Update

DJ

Leer

27 mar 2026, 17:00 UTC

Noticias de Eventos Importantes

ECB Shouldn't Rush Its Response to Iran Conflict, Schnabel Says

DJ

Leer

27 mar 2026, 16:03 UTC

Noticias de Eventos Importantes

Fertilizer Maker Yara Warns Farmers Are Being Squeezed by Price Surge Amid War -- Commodities Roundup

DJ

Leer

27 mar 2026, 14:50 UTC

Principales Movimientos del Mercado

Cybersecurity Stocks Fall on Leak About New Claude Model's Cyber Capabilities

DJ

Leer

27 mar 2026, 14:37 UTC

Adquisiciones, fusiones, absorciones

Nestle's Water Business Stake Sale Could Value Unit at Around $5.76 billion, FT Says, Citing Sources

DJ

Leer

27 mar 2026, 14:29 UTC

Noticias de Eventos Importantes

EU Finance Ministers Tally Economic Hit of Iran War -- Update

DJ

Leer

27 mar 2026, 14:16 UTC

Noticias de Eventos Importantes

The Week in Oil: Mixed Signals Over U.S.-Iran Talks Keep Traders Wary

DJ

Leer

27 mar 2026, 20:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

DJ

Leer

27 mar 2026, 19:16 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Oil Futures Rise On Uncertainty Ahead of Weekend -- Market Talk

DJ

Leer

27 mar 2026, 19:07 UTC

Charlas de Mercado

U.S. Natural Gas Gains As April Contract Expires -- Market Talk

DJ

Leer

27 mar 2026, 19:04 UTC

Charlas de Mercado

Gold Rises But Can't Finish the Week Positive -- Market Talk

DJ

Leer

27 mar 2026, 19:03 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Global Forex and Fixed Income Roundup: Market Talk

DJ

Leer

27 mar 2026, 19:02 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Among Central Banks, Canada Has Room to Handle Oil Inflation -- Market Talk

DJ

Leer

27 mar 2026, 18:12 UTC

Charlas de Mercado

Foreign Fuels and Feedstocks to Get RINs Until 2028 -- Market Talk

DJ

Leer

27 mar 2026, 17:36 UTC

Noticias de Eventos Importantes

The Iran War and Oil Prices Bring Risk of Deeper Market Lows. There Are Echoes of 2008. -- Barrons.com

DJ

Leer

27 mar 2026, 17:34 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Delivery Hero Shares Bounce as Stake-Sale Report Whets Investor Appetites -- Market Talk

DJ

Leer

27 mar 2026, 17:29 UTC

Charlas de Mercado

U.S. Oil Rig Count Falls By 5 to 409 -- Market Talk

DJ

Leer

27 mar 2026, 16:38 UTC

Charlas de Mercado

Carnival's Outlook Assumes Oil Prices Will Come Down -- Market Talk

DJ

Leer

27 mar 2026, 16:32 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Chinese Exposure to Higher Energy Costs Seen as Limited -- Market Talk

DJ

Leer

27 mar 2026, 16:20 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

DJ

Leer

27 mar 2026, 15:43 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Hormuz Closure Sends Tanker Rates to Record Highs -- Market Talk

DJ

Leer

27 mar 2026, 15:25 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

DJ

Leer

27 mar 2026, 15:25 UTC

Charlas de Mercado

Swiss Franc Dented by Rising European Yields, SNB Intervention Threats -- Market Talk

DJ

Leer

27 mar 2026, 15:00 UTC

Noticias de Eventos Importantes

Fed's Barkin: Inflation Progress 'May Be at Risk of Stalling'

DJ

Leer

27 mar 2026, 15:00 UTC

Noticias de Eventos Importantes

Fed's Barkin: Holding Rates Steady in March 'Felt Prudent'

DJ

Leer

27 mar 2026, 15:00 UTC

Noticias de Eventos Importantes

Fed's Barkin Says Iran War Raising Economic Uncertainty

DJ

Leer

27 mar 2026, 14:36 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Rising Yields, Oil Prices Seen as Overreaction -- Market Talk

DJ

Leer

27 mar 2026, 14:26 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Treasury Yields Mixed as Iran Peace Deal Remains Elusive -- Market Talk

DJ

Leer

27 mar 2026, 14:14 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

DJ

Leer

27 mar 2026, 14:14 UTC

Charlas de Mercado

Global Energy Roundup: Market Talk

DJ

Leer

Comparación entre iguales

Cambio de precio

Nektar Therapeutics previsión

Precio Objetivo

By TipRanks

79.41% repunte

Estimación a 12 Meses

Media 127.33 USD  79.41%

Máximo 165 USD

Mínimo 70 USD

De acuerdo con 8 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Nektar Therapeutics Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

8 ratings

7

Comprar

1

Mantener

0

Vender

De acuerdo con 8 analistas que ofrecen calificaciones bursátiles a para Nektar Therapeutics Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

0.5949 / 0.7406Soporte y Resistencia

Corto Plazo

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Medio plazo

Strong Bearish Evidence

All events are bearish.

Largo Plazo

Bearish Evidence

All events are bearish.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Otras acciones del sector

LLY

Eli Lilly and Co.

877.96

↓-2.32%

JNJ

Johnson and Johnson

240.27

↑ +0.43%

ABBV

AbbVie Inc

209.68

↓-0.75%

NVS

Novartis AG

148.25

↓-0.86%

MRK

Merck & Co Inc.

119.68

↑ +0.62%